SI LEGEND
Si Legend develops a therapeutic drug for intractable retinal disease. Retinal pigment epithelial cells derived from iPS cells will be produced and put into practical use as pharmaceuticals.
SI LEGEND
Industry:
Health Care Medical Therapeutics
Address:
Kobe, Kyoto, Japan
Country:
Japan
Status:
Active
Similar Organizations
DEEPSONBIO
DEEPSONBIO develops innovative therapeutic ultrasound devices.
Validus Cellular Therapeutics
Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.
Current Employees Featured
Tadahisa Kagimoto
Tadahisa Kagimoto President / Founder @ Si Legend President / Founder
Founder
Tadahisa Kagimoto